John L. Ryan - 12 Jul 2021 Form 3 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role: Director
Signature: /s/ John Ryan
Issuer symbol: UNCY
Transactions as of: 12 Jul 2021
Net transactions value: $0
Form type: 3
Filing time: 12 Jul 2021, 17:15:00 UTC
Next filing: 09 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	UNCY	Common Stock						58,140	12 Jul 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	UNCY	Employee Stock Option (right to buy)							12 Jul 2021	Common Stock	11,628	$0.0100	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of stock options vested on August 1, 2019, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on August 1, 2022.